Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
5.16
|
13.50
|
13.00
|
12.72
|
13.05
|
12.99
|
|
|
368 353.67
|
526.00
|
5.06
|
18.00
|
13.20
|
12.52
|
13.26
|
12.79
|
|
|
477 461.42
|
694.00
|
5.13
|
18.00
|
13.00
|
12.52
|
13.01
|
12.93
|
|
|
478 528.60
|
982.00
|
10.13
|
18.00
|
13.51
|
12.92
|
13.51
|
13.00
|
|
|
354 603.45
|
776.00
|
10.71
|
18.00
|
13.00
|
12.68
|
13.46
|
13.00
|
|
|
407 372.19
|
1 278.00
|
11.20
|
18.00
|
13.00
|
12.60
|
13.20
|
12.85
|
|
|
762 961.79
|
1 178.00
|
11.57
|
15.60
|
13.65
|
12.5003
|
14.10
|
12.85
|
|
|
1 414 771.64
|
1 241.00
|
12.51
|
15.60
|
15.50
|
13.65
|
15.5994
|
14.03
|
|
|
1 949 912.69
|
1 504.00
|
13.00
|
18.00
|
15.67
|
14.005
|
16.01
|
14.81
|
|
|
3 272 753.80
|
2 197.00
|
6.48
|
16.19
|
16.22
|
14.2376
|
17.40
|
16.14
|
|
|
1 633 800.04
|
1 463.00
|
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. It researches and develops and plans to commercialize cannabinoid derivatives through its own directed research efforts and through several license agreements with the University of Mississippi. The company's lead compound, SBI-100, is initially being developed to treat ocular disease.